Evidence map›Paper›PMID 40821197›Full record

ArticleCureus2025

Management of Congenital Palatal Fistula Associated With Wiskott-Aldrich Syndrome.

Teruyuki Niimi, Nagato Natsume, Hideto Imura, Toko Hayakawa, Hiroo Furukawa

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Teruyuki NiimiDivision of Research and Treatment for Oral Maxillofacial Congenital Anomalies, School of Dentistry, Aichi Gakuin University, Nagoya, JPN.
Nagato NatsumeDivision of Research and Treatment for Oral and Maxillofacial Congenital Anomalies, School of Dentistry, Aichi Gakuin University, Nagoya, JPN.
Hideto ImuraDivision of Research and Treatment for Oral Maxillofacial Congenital Anomalies, School of Dentistry, Aichi Gakuin University, Nagoya, JPN.
Toko HayakawaDivision of Speech, Hearing, and Language, Aichi Gakuin University Dental Hospital, Nagoya, JPN.
Hiroo FurukawaCleft Lip and Palate Center, Aichi Gakuin University Dental Hospital, Nagoya, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Submucous cleft palate (SMCP) is a rare form of cleft palate involving abnormal muscle development in the soft palate. Diagnosis is often delayed, with many cases identified after age 4. Symptoms like hypernasality and velopharyngeal insufficiency (VPI) may appear, though some remain asymptomatic. SMCP diagnosis typically relies on Calnan's triad: bifid uvula, hard palate notch, and zona pellucida. Wiskott-Aldrich syndrome (WAS) is a rare X-linked immune disorder marked by thrombocytopenia, eczema, and infections. Early diagnosis is key to effective treatment. Due to the rarity of both SMCP and WAS, we present a unique case and suggest careful management for optimal outcomes. A one-year and 10-month-old boy with WAS was referred to our cleft center for evaluation of a congenital palatal fistula. There was no history of trauma or surgery, but a 9 × 7 mm midline fistula was observed, along with a diagnosis of SMCP. After hematopoietic stem cell transplantation (HSCT) and continued immunosuppressive therapy, a palatal plate was created to assist feeding. At age 5, a cleft palate repair using a modified Bardach technique was performed. Postoperative healing was successful without complications. This case highlights multidisciplinary management in a patient with both SMCP and WAS.

Indexed as

congenital palatal fistulamanagementoral surgerysubmucous cleft palatewiskott-aldrich syndrome

Identifiers

PMID40821197
PMCPMC12357214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.